Peptron, Inc. (KOSDAQ:087010)
South Korea
· Delayed Price · Currency is KRW 277,500
-3,500 (-1.25%)
Sep 26, 2025, 3:30 PM KST
Peptron Revenue
Peptron had revenue of 1.43B KRW in the quarter ending June 30, 2025, with 163.05% growth. This brings the company's revenue in the last twelve months to 5.18B, up 106.96% year-over-year. In the year 2024, Peptron had annual revenue of 3.15B, down -5.68%.
Revenue (ttm)
5.18B
Revenue Growth
+106.96%
P/S Ratio
1,249.43
Revenue / Employee
n/a
Employees
n/a
Market Cap
6,470.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.15B | -189.71M | -5.68% |
| Dec 31, 2023 | 3.34B | -2.47B | -42.52% |
| Dec 31, 2022 | 5.81B | -810.52M | -12.24% |
| Dec 31, 2021 | 6.62B | 3.50B | 112.28% |
| Dec 31, 2020 | 3.12B | 1.32B | 73.26% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,031.69B |
| Celltrion | 3,748.95B |
| ALTEOGEN | 158.06B |
| Yuhan | 2,165.44B |
| SK Biopharmaceuticals | 620.28B |
| PharmaResearch | 449.81B |
| LigaChem Biosciences | 148.28B |
| HLB Co., Ltd. | 75.57B |